1.19
|
4.26e-26
|
GO:0044237
|
cellular metabolic process
|
1.10
|
7.26e-25
|
GO:0009987
|
cellular process
|
1.20
|
1.20e-18
|
GO:0044260
|
cellular macromolecule metabolic process
|
1.14
|
2.66e-18
|
GO:0008152
|
metabolic process
|
1.14
|
6.09e-15
|
GO:0044238
|
primary metabolic process
|
1.16
|
7.03e-13
|
GO:0043170
|
macromolecule metabolic process
|
1.22
|
9.23e-11
|
GO:0006139
|
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.24
|
1.96e-10
|
GO:0048523
|
negative regulation of cellular process
|
1.20
|
2.12e-10
|
GO:0034641
|
cellular nitrogen compound metabolic process
|
1.18
|
5.88e-10
|
GO:0071840
|
cellular component organization or biogenesis
|
1.18
|
5.94e-10
|
GO:0016043
|
cellular component organization
|
1.19
|
6.37e-10
|
GO:0006807
|
nitrogen compound metabolic process
|
1.21
|
1.22e-09
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
1.18
|
1.42e-09
|
GO:0031323
|
regulation of cellular metabolic process
|
1.21
|
1.76e-09
|
GO:0071842
|
cellular component organization at cellular level
|
1.22
|
2.15e-09
|
GO:0048519
|
negative regulation of biological process
|
1.35
|
4.31e-09
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
1.21
|
6.51e-09
|
GO:0048522
|
positive regulation of cellular process
|
1.18
|
7.52e-09
|
GO:0060255
|
regulation of macromolecule metabolic process
|
1.11
|
7.99e-09
|
GO:0050794
|
regulation of cellular process
|
1.21
|
1.09e-08
|
GO:0044249
|
cellular biosynthetic process
|
1.26
|
2.02e-08
|
GO:0006996
|
organelle organization
|
1.36
|
2.46e-08
|
GO:0006351
|
transcription, DNA-dependent
|
1.20
|
2.52e-08
|
GO:0048518
|
positive regulation of biological process
|
1.22
|
3.09e-08
|
GO:0090304
|
nucleic acid metabolic process
|
1.15
|
4.01e-08
|
GO:0019222
|
regulation of metabolic process
|
1.20
|
4.78e-08
|
GO:0009058
|
biosynthetic process
|
1.16
|
6.36e-08
|
GO:0080090
|
regulation of primary metabolic process
|
1.24
|
1.53e-07
|
GO:0016070
|
RNA metabolic process
|
1.33
|
3.94e-07
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
1.20
|
5.21e-07
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
1.33
|
5.44e-07
|
GO:0031324
|
negative regulation of cellular metabolic process
|
1.18
|
6.08e-07
|
GO:0031326
|
regulation of cellular biosynthetic process
|
1.38
|
6.30e-07
|
GO:0009890
|
negative regulation of biosynthetic process
|
1.38
|
6.61e-07
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
1.09
|
7.63e-07
|
GO:0050789
|
regulation of biological process
|
1.19
|
9.95e-07
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
1.31
|
1.16e-06
|
GO:0009892
|
negative regulation of metabolic process
|
1.18
|
1.20e-06
|
GO:0009889
|
regulation of biosynthetic process
|
1.25
|
1.25e-06
|
GO:0007399
|
nervous system development
|
1.38
|
1.54e-06
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
1.31
|
1.80e-06
|
GO:0032774
|
RNA biosynthetic process
|
1.19
|
1.95e-06
|
GO:0044267
|
cellular protein metabolic process
|
1.09
|
2.12e-06
|
GO:0065007
|
biological regulation
|
1.39
|
2.89e-06
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
1.19
|
4.74e-06
|
GO:0051252
|
regulation of RNA metabolic process
|
1.21
|
5.07e-06
|
GO:0010467
|
gene expression
|
1.42
|
5.17e-06
|
GO:0007169
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
1.26
|
9.25e-06
|
GO:0051641
|
cellular localization
|
1.17
|
1.10e-05
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.36
|
1.20e-05
|
GO:0007167
|
enzyme linked receptor protein signaling pathway
|
1.22
|
1.29e-05
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
1.33
|
1.31e-05
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.38
|
1.33e-05
|
GO:0010629
|
negative regulation of gene expression
|
1.17
|
1.44e-05
|
GO:0010468
|
regulation of gene expression
|
1.21
|
1.47e-05
|
GO:0006464
|
protein modification process
|
1.33
|
1.89e-05
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
1.35
|
1.99e-05
|
GO:0051254
|
positive regulation of RNA metabolic process
|
1.39
|
2.39e-05
|
GO:0051253
|
negative regulation of RNA metabolic process
|
1.16
|
2.51e-05
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
1.21
|
2.81e-05
|
GO:0009059
|
macromolecule biosynthetic process
|
1.60
|
3.43e-05
|
GO:0048011
|
nerve growth factor receptor signaling pathway
|
1.26
|
3.64e-05
|
GO:0031325
|
positive regulation of cellular metabolic process
|
1.36
|
3.83e-05
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.26
|
4.01e-05
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
1.25
|
4.42e-05
|
GO:0009893
|
positive regulation of metabolic process
|
1.39
|
4.64e-05
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
1.36
|
5.27e-05
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
1.18
|
1.11e-04
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
1.22
|
1.12e-04
|
GO:0009653
|
anatomical structure morphogenesis
|
1.13
|
1.54e-04
|
GO:0051179
|
localization
|
1.19
|
1.75e-04
|
GO:0043412
|
macromolecule modification
|
1.22
|
2.22e-04
|
GO:0009966
|
regulation of signal transduction
|
1.25
|
2.70e-04
|
GO:0051649
|
establishment of localization in cell
|
1.26
|
3.08e-04
|
GO:0007049
|
cell cycle
|
1.20
|
3.81e-04
|
GO:0023051
|
regulation of signaling
|
1.14
|
5.27e-04
|
GO:0048856
|
anatomical structure development
|
1.28
|
6.97e-04
|
GO:0051128
|
regulation of cellular component organization
|
1.29
|
8.47e-04
|
GO:0046907
|
intracellular transport
|
1.32
|
8.67e-04
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
1.32
|
9.59e-04
|
GO:0032989
|
cellular component morphogenesis
|
1.32
|
1.28e-03
|
GO:0051726
|
regulation of cell cycle
|
1.53
|
1.62e-03
|
GO:0045786
|
negative regulation of cell cycle
|
1.32
|
1.75e-03
|
GO:0000902
|
cell morphogenesis
|
1.43
|
1.75e-03
|
GO:0071495
|
cellular response to endogenous stimulus
|
1.37
|
1.77e-03
|
GO:0060548
|
negative regulation of cell death
|
1.52
|
2.17e-03
|
GO:0071375
|
cellular response to peptide hormone stimulus
|
1.16
|
2.17e-03
|
GO:0048869
|
cellular developmental process
|
1.24
|
2.95e-03
|
GO:0043067
|
regulation of programmed cell death
|
1.12
|
3.02e-03
|
GO:0032502
|
developmental process
|
1.24
|
3.12e-03
|
GO:0042981
|
regulation of apoptosis
|
1.26
|
3.35e-03
|
GO:0016265
|
death
|
1.26
|
4.06e-03
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
1.26
|
4.15e-03
|
GO:0008219
|
cell death
|
1.27
|
4.58e-03
|
GO:0016192
|
vesicle-mediated transport
|
1.23
|
4.68e-03
|
GO:0010941
|
regulation of cell death
|
1.13
|
4.71e-03
|
GO:0019538
|
protein metabolic process
|
1.56
|
4.82e-03
|
GO:0032869
|
cellular response to insulin stimulus
|
1.29
|
5.65e-03
|
GO:0010628
|
positive regulation of gene expression
|
1.26
|
5.98e-03
|
GO:0022402
|
cell cycle process
|
1.36
|
6.02e-03
|
GO:0032583
|
regulation of gene-specific transcription
|
1.37
|
6.70e-03
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
1.13
|
6.89e-03
|
GO:0051234
|
establishment of localization
|
1.26
|
7.36e-03
|
GO:0033554
|
cellular response to stress
|
1.13
|
7.39e-03
|
GO:0048731
|
system development
|
1.39
|
8.33e-03
|
GO:0016568
|
chromatin modification
|
1.67
|
9.49e-03
|
GO:0007265
|
Ras protein signal transduction
|
1.35
|
1.06e-02
|
GO:0043069
|
negative regulation of programmed cell death
|
1.47
|
1.09e-02
|
GO:0007507
|
heart development
|
1.25
|
1.10e-02
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.33
|
1.15e-02
|
GO:0072358
|
cardiovascular system development
|
1.33
|
1.15e-02
|
GO:0072359
|
circulatory system development
|
1.13
|
1.18e-02
|
GO:0006810
|
transport
|
1.35
|
1.36e-02
|
GO:0043066
|
negative regulation of apoptosis
|
1.15
|
1.47e-02
|
GO:0030154
|
cell differentiation
|
1.41
|
1.76e-02
|
GO:0032870
|
cellular response to hormone stimulus
|
1.33
|
1.86e-02
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
1.26
|
1.99e-02
|
GO:0006915
|
apoptosis
|
1.41
|
2.22e-02
|
GO:0006366
|
transcription from RNA polymerase II promoter
|
1.22
|
2.29e-02
|
GO:0006793
|
phosphorus metabolic process
|
1.22
|
2.29e-02
|
GO:0006796
|
phosphate metabolic process
|
1.91
|
2.42e-02
|
GO:0061008
|
hepaticobiliary system development
|
1.26
|
2.54e-02
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
1.31
|
2.57e-02
|
GO:0032990
|
cell part morphogenesis
|
1.48
|
2.68e-02
|
GO:0043193
|
positive regulation of gene-specific transcription
|
1.23
|
2.70e-02
|
GO:0022008
|
neurogenesis
|
1.11
|
3.26e-02
|
GO:0007275
|
multicellular organismal development
|
1.25
|
3.66e-02
|
GO:0012501
|
programmed cell death
|
1.21
|
3.82e-02
|
GO:0051246
|
regulation of protein metabolic process
|
1.26
|
3.86e-02
|
GO:0009790
|
embryo development
|
1.20
|
3.98e-02
|
GO:0044248
|
cellular catabolic process
|
1.36
|
4.07e-02
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
1.35
|
4.57e-02
|
GO:0007264
|
small GTPase mediated signal transduction
|
1.89
|
4.65e-02
|
GO:0001889
|
liver development
|